|Articles|November 11, 2011

Medical Economics, Digital Edition - Supplement, November 10th, 2011

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition - Supplement, November 10th, 2011

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Are payors downcoding your evaluation and management services? Why every practice should be paying attention

Kennedy asks the public to weigh in on the AMA's control of codes by Sept. 14

Physicians have 5 responsibilities that AI will not replace: AMA

Stop calling it ‘savings’: the real economics of closing Medicare care gaps

Physician pay growth cooled in 2026 — but bonuses didn't